Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.

Source:http://linkedlifedata.com/resource/pubmed/id/16797163

Download in:

View as

General Info

PMID
16797163